Organoidsciences

Organoidsciences develops miniature three-dimensional tissue structures, called organoids, that closely mimic human organs, and uses them to create regenerative therapies and drug-testing tools.

Its customers include pharmaceutical and cosmetics companies seeking more accurate alternatives to conventional cell and animal testing, as well as hospitals using its precision-medicine service to match cancer patients with the most suitable immunotherapy drugs. Listed on KOSDAQ, Korea's tech-focused small-cap board, the company operates across four business lines: regenerative therapeutics, a new-material evaluation service, a research-reagent product range, and contract development and manufacturing.